Bovine lactoferrin ameliorates ferric nitrilotriacetate-induced renal oxidative damage in rats

Journal of Clinical Biochemistry and Nutrition

Volumn 51, Issue 2, 2012, Pages 84-90

  Okazaki, Yasumasa ^a,b   Kono, Isato ^c   Kuriki, Takayoshi ^d   Funahashi, Satomi ^a   Fushimi, Soichiro ^b   Iqbal, Mohammad ^b,e   Okada, Shigeru ^b   Toyokuni, Shinya ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

^c INDUSTRIAL TECHNOLOGY CENTER OF OKAYAMA PREFECTURE   (Japan)

^d Okayama Prefectual Center for Animal Husbandry and Research   (Japan)

^e UNIVERSITI MALAYSIA SABAH   (Malaysia)

Author keywords

Chemoprevention; Ferric nitrilotriacetate; Glutathione metabolism; Lactoferrin; Oxidative renal damage

Indexed keywords

ANTIOXIDANT; CREATININE; LACTOFERRIN; NITRILOTRIACETATE IRON;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COLON POLYP; CONTROLLED STUDY; COW; CREATININE BLOOD LEVEL; DIETARY INTAKE; ENZYME ACTIVITY; KIDNEY TUBULE DAMAGE; MALE; NONHUMAN; OXIDATIVE STRESS; RAT; UREA NITROGEN BLOOD LEVEL;

BOVINAE; RATTUS;

EID: 84865982429     PISSN: 09120009     EISSN: None     Source Type: Journal    
DOI: 10.3164/jcbn.11-100     Document Type: Article

References (47)

1. Toyokuni S. Iron as a target of chemoprevention for longevity in humans. Free Radic Res 2011; 45: 906-917.
2. Diplock AT, Charleux JL, Crozier-Willi G, et al. Functional food science and defence against reactive oxidative species. Br J Nutr 1998; 80 (Suppl 1): S77-S112.
3. Raghuveer TS, McGuire EM, Martin SM, et al. Lactoferrin in the preterm infants' diet attenuates iron-induced oxidation products. Pediatr Res 2002; 52: 964-972. (Pubitemid 35379480)
4. Lönnerdal B. Nutritional and physiologic significance of human milk proteins. Am J Clin Nutr 2003; 77: 1537S-1543S.
5. Aisen P, Leibman A. Lactoferrin and transferrin: a comparative study. Biochim Biophys Acta 1972; 257: 314-323.
6. Levay PF, Viljoen M. Lactoferrin: a general review. Haematologica 1995; 80: 252-267.
7. Metz-Boutigue MH, Jollès J, Mazurier J, et al. Human lactotransferrin: amino acid sequence and structural comparisons with other transferrins. Eur J Biochem 1984; 145: 659-676.
8. Ghio AJ, Carter JD, Richards JH, Brighton LE, Lay JC, Devlin RB. Disruption of normal iron homeostasis after bronchial instillation of an iron-containing particle. Am J Physiol 1998; 274: L396-L403.
9. Ghio AJ, Stonehuerner J, Richards J, Devlin RB. Iron homeostasis in the lung following asbestos exposure. Antioxid Redox Signal 2008; 10: 371-377.
10. Ward PP, Mendoza-Meneses M, Cunningham GA, Conneely OM. Iron status in mice carrying a targeted disruption of lactoferrin. Mol Cell Biol 2003; 23: 178-185. (Pubitemid 36008511)
11. Takeuchi T, Shimizu H, Ando K, Harada E. Bovine lactoferrin reduces plasma triacylglycerol and NEFA accompanied by decreased hepatic cholesterol and triacylglycerol contents in rodents. Br J Nutr 2004; 91: 533-538. (Pubitemid 38584777)
12. 3+ to displace it from the surface of asbestos. Arch Biochem Biophys 1994; 315: 219-225.
13. Tsubota A, Yoshikawa T, Nariai K, et al. Bovine lactoferrin potently inhibits liver mitochondrial 8-OHdG levels and retrieves hepatic OGG1 activities in Long-Evans Cinnamon rats. J Hepatol 2008; 48: 486-493.
14. Konishi M, Iwasa M, Yamauchi K, et al. Lactoferrin inhibits lipid peroxidation in patients with chronic hepatitis C. Hepatol Res 2006; 36: 27-32. (Pubitemid 44309286)
15. Jonasch E, Stadler WM, Bukowski RM, et al. Phase 2 trial of talactoferrin in previously treated patients with metastatic renal cell carcinoma. Cancer 2008; 113: 72-77. (Pubitemid 351976388)
16. Tsuda H, Kozu T, Iinuma G, et al. Cancer prevention by bovine lactoferrin: from animal studies to human trial. Biometals 2010; 23: 399-409.
17. Hamazaki S, Okada S, Ebina Y, Midorikawa O. Acute renal failure and glucosuria induced by ferric nitrilotriacetate in rats. Toxicol Appl Pharmacol 1985; 77: 267-274. (Pubitemid 15128372)
18. Hamazaki S, Okada S, Toyokuni S, Midorikawa O. Thiobarbituric acid-reactive substance formation of rat kidney brush border membrane vesicles induced by ferric nitrilotriacetate. Arch Biochem Biophys 1989; 274: 348-354. (Pubitemid 19261130)
19. Toyokuni S. Reactive oxygen species-induced molecular damage and its application in pathology. Pathol Int 1999; 49: 91-102. (Pubitemid 29133467)
20. Uchida K, Fukuda A, Kawakishi S, Hiai H, Toyokuni S. A renal carcinogen ferric nitrilotriacetate mediates a temporary accumulation of aldehyde-modified proteins within cytosolic compartment of rat kidney. Arch Biochem Biophys 1995; 317: 405-411.
21. Toyokuni S, Uchida K, Okamoto K, Hattori-Nakakuki Y, Hiai H, Stadtman ER. Formation of 4-hydroxy-2-nonenal-modified proteins in the renal proximal tubules of rats treated with a renal carcinogen, ferric nitrilotriacetate. Proc Natl Acad Sci USA 1994; 91: 2616-2620. (Pubitemid 24139398)
22. 7-12 acyloins in the kidney of Wistar rats after treatment with a renal carcinogen, ferric nitrilotriacetate. Free Radic Biol Med 1997; 22: 1019-1027. (Pubitemid 27084139)
23. Toyokuni S, Miyake N, Hiai H, et al. The monoclonal antibody specific for the 4-hydroxy-2-nonenal histidine adduct. FEBS Lett 1995; 359: 189-191.
24. Toyokuni S, Tanaka T, Hattori Y, et al. Quantitative immunohistochemical determination of 8-hydroxy-2′-deoxyguanosine by a monoclonal antibody N45.1: its application to ferric nitrilotriacetate-induced renal carcinogenesis model. Lab Invest 1997; 76: 365-374. (Pubitemid 27157344)
25. INK4A tumor suppressor genes in oxystress-induced renal cell carcinoma of rats. Oncogene 1999; 18: 3793-3797. (Pubitemid 29338514)
26. INK4A tumor suppressor gene after weeks of iron-mediated oxidative damage during rat renal carcinogenesis. Am J Pathol 2002; 160: 419-424. (Pubitemid 34160318)
27. Tanaka T, Akatsuka S, Ozeki M, Shirase T, Hiai H, Toyokuni S. Redox regulation of annexin 2 and its implications for oxidative stress-induced renal carcinogenesis and metastasis. Oncogene 2004; 23: 3980-3989. (Pubitemid 38747926)
28. Liu YT, Shang D, Akatsuka S, et al. Chronic oxidative stress causes amplification and overexpression of ptprz1 protein tyrosine phosphatase to activate beta-catenin pathway. Am J Pathol 2007; 171: 1978-1988.
29. Zhong Y, Onuki J, Yamasaki T, Ogawa O, Akatsuka S, Toyokuni S. Genome-wide analysis identifies a tumor suppressor role for aminoacylase 1 in iron-induced rat renal cell carcinoma. Carcinogenesis 2009; 30: 158-164.
30. Zhang D, Okada S, Yu Y, Zheng P, Yamaguchi R, Kasai H. Vitamin E inhibits apoptosis, DNA modification, and cancer incidence induced by iron-mediated peroxidation in Wistar rat kidney. Cancer Res 1997; 57: 2410-2414. (Pubitemid 27255899)
31. Okazaki Y, Iqbal M, Okada S. Suppressive effects of dietary curcumin on the increased activity of renal ornithine decarboxylase in mice treated with a renal carcinogen, ferric nitrilotriacetate. Biochim Biophys Acta 2005; 1740: 357-366.
32. Okazaki Y, Iqbal M, Kawakami N, Yamamoto Y, Toyokuni S, Okada S. A beverage containing fermented black soybean ameliorates ferric nitrilotriacetate-induced renal oxidative damage in rats. J Clin Biochem Nutr 2010; 47: 198-207.
33. Okada S. Prevention of free-radical mediated tissue damage and carcinogenesis induced by low-molecular-weight iron. Biometals 2003; 16: 99-101. (Pubitemid 36140220)
34. Awai M, Narasaki M, Yamanoi Y, Seno S. Induction of diabetes in animals by parenteral administration of ferric nitrilotriacetate. A model of experimental hemochromatosis. Am J Pathol 1979; 95: 663-673. (Pubitemid 9201266)
35. Mohandas J, Marshall JJ, Duggin GG, Horvath JS, Tiller DJ. Low activities of glutathione-related enzymes as factors in the genesis of urinary bladder cancer. Cancer Res 1984; 44: 5086-5091. (Pubitemid 15204468)
36. Carlberg I, Mannervik B. Purification and characterization of the flavoenzyme glutathione reductase from rat liver. J Biol Chem 1975; 250: 5475-5480.
37. Tanaka T, Nishiyama Y, Okada K, et al. Induction and nuclear translocation of thioredoxin by oxidative damage in the mouse kidney: independence of tubular necrosis and sulfhydryl depletion. Lab Invest 1997; 77: 145-155. (Pubitemid 27355911)
38. Burrow H, Kanwar RK, Kanwar JR. Antioxidant enzyme activities of iron-saturated bovine lactoferrin (Fe-bLf) in human gut epithelial cells under oxidative stress. Med Chem 2011; 7: 224-230.
39. Yamauchi K, Toida T, Nishimura S, et al. 13-Week oral repeated administration toxicity study of bovine lactoferrin in rats. Food Chem Toxicol 2000; 38: 503-512. (Pubitemid 30319350)
40. Wakabayashi H, Kuwata H, Yamauchi K, Teraguchi S, Tamura Y. No detectable transfer of dietary lactoferrin or its functional fragments to portal blood in healthy adult rats. Biosci Biotechnol Biochem 2004; 68: 853-860. (Pubitemid 39251455)
41. Gosriwatana I, Loreal O, Lu S, Brissot P, Porter J, Hider RC. Quantification of non-transferrin-bound iron in the presence of unsaturated transferrin. Anal Biochem 1999; 273: 212-220. (Pubitemid 29430665)
42. Sasaki K, Ikuta K, Tanaka H, et al. Improved quantification for non-transferrin-bound iron measurement using high-performance liquid chromatography by reducing iron contamination. Mol Med Report 2011; 4: 913-918.
43. Igarashi M, Watanabe M, Yoshida M, et al. Enhancement of lung carcinogenesis initiated with 4-(N-hydroxymethylnitrosamino)-1-(3-pyridyl)-1- butanone by Ogg1 gene deficiency in female, but not male, mice. J Toxicol Sci 2009; 34: 163-174.
44. Matsuda Y, Saoo K, Hosokawa K, et al. Post-initiation chemopreventive effects of dietary bovine lactoferrin on 4-(methylnitrosamino)-1-(3-pyridyl)-1- butanone-induced lung tumorigenesis in female A/J mice. Cancer Lett 2007; 246: 41-46. (Pubitemid 44959376)
45. Li L, Huang L, Vergis AL, et al. IL-17 produced by neutrophils regulates IFN-gamma-mediated neutrophil migration in mouse kidney ischemia-reperfusion injury. J Clin Invest 2010; 120: 331-342.
46. Deguchi J, Kawabata T, Kondo A, Okada S. Transforming growth factor-alpha expression of renal proximal tubules in Wistar rats treated with ferric and aluminum nitrilotriacetate. Jpn J Cancer Res 1993; 84: 649-655. (Pubitemid 23222190)
47. Hida AI, Kawabata T, Minamiyama Y, Mizote A, Okada S. Saccharated colloidal iron enhances lipopolysaccharide-induced nitric oxide production in vivo. Free Radic Biol Med 2003; 34: 1426-1434. (Pubitemid 36570416)